SOUTH SAN FRANCISCO, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company...
Alleviates chemotherapy-induced neuropathyCounteracts tumor promoting signals induced by Antibody Drug Conjugate (ADC) payloadsLUND, SWEDEN / ACCESSWIRE / February 12, 2024...
Cholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio choleraeCrofelemer previously granted Orphan...
Bedtime TNX-102 SL improves sleep quality in PTSD and is also being developed for the management of fibromyalgia for which...
The Company’s two largest stockholders holding approximately 45% of the Company’s outstanding shares have extended their lock-up agreements for an...
Approval triggered by positive results from ReSTORE Phase III clinical trialPayment will advance Cidara’s Cloudbreak platform for the development of...
4D-310 demonstrated clinically meaningful cardiac endpoint improvements through 12-24 months in contractility (echocardiography), peak VO2 (cardiopulmonary exercise testing) and/or cardiac...
Designation for BXCL701 in combination with a checkpoint inhibitor (CPI) for treatment of patients with metastatic SCNC with progression on...
Independent Research Confirms >$10bn Market Opportunity for POLB 001 as a Preventative Therapy for Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)Former...
The FDA has accepted a New Drug Application filed by Lykos Therapeutics for MDMA-assisted therapy for PTSD The application was...
MacNaughton to Lead Business into Enterprise-first EraNEW YORK--(BUSINESS WIRE)--Please replace the release dated February 8, 2024 with the following corrected...
PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light Holland Toronto, Ontario--(Newsfile Corp. - February 9,...
Fort Lee, NJ, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light HollandVANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE...
– BLA submission supported by results from Phase 2/3 clinical trial and outcomes of real-world use of the HAV under...
News of the Successful Trial Comes Amid an Oversubscribed Investor Round and Preparation for Series A Financing RoundRALEIGH, NC /...
MacNaughton to Lead Business into Enterprise-first Era, with OptumRx as Strategic PartnerNEW YORK--(BUSINESS WIRE)--Calibrate, the leading clinician-guided and value-based obesity...
NASHVILLE, TN / ACCESSWIRE / February 8, 2024 / Profound Research, a leading clinical trial site network, today announced key...
IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)...
IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)...